Review of Cannabinoid Clinical Trials for Mental Health Treatment
This cannabinoid clinical trials mental health treatment review summarizes current evidence on cannabinoids' efficacy and safety for mental health disorders. The review highlights consistent adverse effects reported in trials. Careful clinical monitoring…
Why People Use Cannabis Predicts Whether Use Becomes Harmful, Review Finds
A 2024 narrative review highlights that cannabis use motives, particularly coping motives, strongly predict cannabis-related problems and disorder. Medical and coping motives overlap, complicating clinical assessment. Understanding cannabis use motives…
Randomised Controlled Trial Evidence on Medicinal Cannabis for Treatment of Mental Health and Substance Use Disorders: A Scoping Review.
This scoping review synthesizes randomised controlled trial evidence medicinal cannabis for treating mental health and substance use disorders. The review addresses previous limitations in study design and quality. It provides clinicians with a clearer…
Cannabinoids for Mental & Substance Use Disorders: Evidence
Current evidence on cannabinoids for substance use disorders shows limited and inconsistent benefits. Safety concerns remain a consistent finding across clinical trials. The efficacy of cannabinoids for mental and substance use disorders remains…
Cannabinoid Clinical Trials for Mental & Substance Disorders
Cannabinoid clinical trials mental disorders reveal limited evidence supporting cannabinoids as primary treatments. Current data do not establish clear efficacy or safety profiles. Clinicians should interpret patient interest with caution until stronger…
Endocannabinoid System Research: Cannabis for PTSD & SUDs
Endocannabinoid system research cannabis PTSD meta-analysis reveals trauma-focused treatments remain effective for individuals using cannabis. People with PTSD and co-occurring substance use disorders show comparable outcomes regardless of cannabis use.…
Cannabinoid Clinical Trials for Mental Health: Key Findings
Cannabinoid clinical trials mental health evidence remains limited and inconclusive. Current research does not establish clear efficacy or safety profiles for cannabinoids in mental health treatment. Clinicians should interpret approvals cautiously given…
The efficacy and safety of cannabinoids for mental and substance use disorders
This review examines cannabinoids for mental substance use disorders evidence, focusing on their efficacy and safety. Mental health and substance use disorders are common reasons for cannabinoid use. The study highlights the need for careful clinical…
Research Digest: 40 Recent Cannabis Clinical Studies – March 20, 2026
This research digest cannabis clinical studies March 2026 compiles 40 recent peer-reviewed studies curated for clinical relevance and evidence quality. It highlights key findings from cannabis clinical research and evidence reviews. Stay informed with…
Cannabinoid Clinical Trials: PTSD and Substance Use
Cannabinoid clinical trials PTSD substance use reveal that cannabis does not reduce the effectiveness of trauma-focused treatments. People with PTSD and substance use disorders benefit from evidence-based therapies despite cannabis use. These trials…